RSRC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.160200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.807400E-01
Normal-vs-Stage2
7.631000E-01
Normal-vs-Stage3
2.665400E-01
Normal-vs-Stage4
4.797600E-01
Stage1-vs-Stage2
4.858000E-01
Stage1-vs-Stage3
9.302300E-02
Stage1-vs-Stage4
4.567600E-01
Stage2-vs-Stage3
1.500450E-01
Stage2-vs-Stage4
3.863200E-01
Stage3-vs-Stage4
1.566960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.358600E-01
Normal-vs-AfricanAmerican
7.259200E-01
Normal-vs-Asian
9.144400E-01
Caucasian-vs-AfricanAmerican
7.737800E-01
Caucasian-vs-Asian
5.476600E-01
AfricanAmerican-vs-Asian
5.634800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.286000E-01
Normal-vs-Female
7.912200E-01
Male-vs-Female
8.674000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.804400E-01
Normal-vs-Age(41-60Yrs)
4.497800E-01
Normal-vs-Age(61-80Yrs)
9.960600E-01
Normal-vs-Age(81-100Yrs)
8.894400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.221400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.969400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.177200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.857900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.989600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.736200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.820600E-01
Normal-vs-Daily Drinker
4.501600E-01
Normal-vs-Weekly Drinker
8.984600E-01
Normal-vs-Occasional Drinker
5.193200E-01
Normal-vs-Social Drinker
3.428200E-01
Non Drinker-vs-Daily Drinker
1.297760E-01
Non Drinker-vs-Weekly Drinker
8.488000E-01
Non Drinker-vs-Occasional Drinker
1.228200E-01
Non Drinker-vs-Social Drinker
6.728100E-02
Daily Drinker-vs-Weekly Drinker
1.337160E-01
Daily Drinker-vs-Occasional Drinker
2.101900E-02
Daily Drinker-vs-Social Drinker
2.803000E-03
Weekly Drinker-vs-Occasional Drinker
2.760200E-01
Weekly Drinker-vs-Social Drinker
1.557630E-01
Occasional Drinker-vs-Social Drinker
9.392800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.373400E-01
Normal-vs-Grade 2
2.085800E-01
Normal-vs-Grade 3
1.613990E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.751600E-01
Grade 1-vs-Grade 3
4.268500E-02
Grade 1-vs-Grade 4
5.373400E-01
Grade 2-vs-Grade 3
1.161390E-01
Grade 2-vs-Grade 4
2.085800E-01
Grade 3-vs-Grade 4
1.613990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.929800E-01
Normal-vs-NonDiabetic
7.993400E-01
Diabetic-vs-NonDiabetic
2.316000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.560600E-01
Normal-vs-NoPancreatitis
8.421800E-01
Pancreatitis-vs-NoPancreatitis
9.599200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.192200E-01
Normal-vs-N1
7.461200E-01
N0-vs-N1
4.688000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.922000E-01
Normal-vs-TP53-NonMutant
9.109400E-01
TP53-Mutant-vs-TP53-NonMutant
4.615900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
